Skip to content
Dose Brief
Menu

Research

Evidence-based research

Every sourced explainer this desk publishes on GLP-1 medicines, grouped by the question it answers. 58 evidence and access guides, plus 7 provider-review articles, with 276 references. Sources include clinical studies, regulators, public agencies and provider terms. For a provider or comparison outside this research collection, the complete site directory groups every page by type. Most recently updated .

Looking for the companies rather than the evidence? Every GLP-1 provider we track is scored and written up on the provider brief index — with prices, limitations and questions to ask before choosing.

Filter by topic

65 articles

What the trials actually showed

The published evidence on the molecules themselves, with every claim tied to a primary source.

Compounded medicines, and what that word means

What a compounding pharmacy is, what the FDA does and does not review, how to check one, and how the brand-name products actually differ from a compounded version.

What it costs, and why that moves

Pricing structures, the mechanics behind a price change, how to read a headline rate, and how insurance coverage actually works.

Dosing, injection & safety

Titration schedules, injection technique, side effects worth knowing about, and specific safety questions like alcohol and low-dose regimens.

Results — what to expect, and when it stalls

A realistic timeline, the evidence on plateaus and muscle preservation, and what happens if you stop.

Access & eligibility

Telehealth prescribing rules, and the current guidance on fertility, pregnancy, and PCOS.

Providers we read, and what their pricing actually says

Separate consumer reviews based on provider program pages, prices and terms. These are not clinical research papers; commercial relationships are disclosed.